Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 55 years or older
- Scans show the cancer is in only one single spot in the breast (not spread to multiple areas)
- The breast tumour measures 3cm or smaller based on imaging scans
- Scans show no signs that the cancer has spread to the lymph nodes under the arm
- Biopsy results show the cancer is strongly driven by hormones (oestrogen and progesterone positive) and tests negative for a protein called HER2
- The tumour is classed as grade 1 or 2 (meaning it is slower-growing) based on biopsy results
- You have chosen to have a full breast removal (mastectomy) as your treatment
Who may not be able to join:
- Your cancer is at an advanced local stage (T3 or T4) or has spread to other parts of the body (stage IV)
- It is already known before surgery that the cancer has spread to your lymph nodes
- You have cancer in both breasts
- You are planned to have chemotherapy before surgery (neoadjuvant chemotherapy)
- You have or have had another type of cancer (confirm with trial site)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 96392353
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
short term outcomes; short term outcomes; short term outcomes; long term outcomes; long term outcomes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.